Literature DB >> 14615212

A unifying view of ageing and disease: the double-agent theory.

Nick Lane1.   

Abstract

The quest for therapies based on molecular genetics (pharmacogenomics, DNA microarrays, etc.) drives pharmaceutical research into individual diseases of old age, but has failed to deliver an unequivocal clinical breakthrough. Attempts to treat most age-related diseases using antioxidant supplements have been equally disappointing, despite the clear benefits of a healthy diet. The double-agent theory is a new, unifying synthesis that draws on flaws in three leading theories of ageing. It argues that there is a tradeoff between oxidative stress as a critical redox signal that marshals genetic defences against physiological stress (such as infection) and oxidative stress as a cause of ageing and age-related disease. The stress response and ageing are linked by redox-sensitive transcription factors, such as NFkappaB. Ageing is a function of rising intracellular oxidative stress, rather than chronological time, but this relationship is obscured because free-radical leakage from mitochondria also tends to rise with age. Mitochondrial leakage produces a genetic response which mirrors that following infection, but because mitochondrial leakage is continuous the shift in gene expression is persistent, leading to the chronic inflammation characteristic of old age. Age-related diseases are thus the price we pay for redox control of stress-gene expression. Because the selective pressure favouring the stress response in youth is stronger than that penalising degenerative diseases after reproductive decline, we may be homeostatically refractory to antioxidant supplements that 'swamp' the redox switch. Furthermore, because genetic selection takes place predominantly in the reductive homeostatic environment of youth, alleles associated with age-related diseases are not inherently damaging (they do not inevitably express a negative effect over time), but are simply less effective in the oxidising conditions of old age. Gene therapies for age-related diseases are unlikely to succeed unless oxidative stress can be controlled physiologically, thereby altering the activity and function of potentially hundreds of genes.

Entities:  

Mesh:

Year:  2003        PMID: 14615212     DOI: 10.1016/s0022-5193(03)00304-7

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  29 in total

Review 1.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

Review 2.  Evolution, kidney development, and chronic kidney disease.

Authors:  Robert L Chevalier
Journal:  Semin Cell Dev Biol       Date:  2018-06-05       Impact factor: 7.727

3.  Introduction of an additional pathway for lactate oxidation in the treatment of lactic acidosis and mitochondrial dysfunction in Caenorhabditis elegans.

Authors:  Leslie I Grad; Leanne C Sayles; Bernard D Lemire
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

4.  Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways.

Authors:  Heather S Smallwood; Daniel López-Ferrer; Thomas C Squier
Journal:  Biochemistry       Date:  2011-10-19       Impact factor: 3.162

Review 5.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

Review 6.  Oxygen free radicals and redox biology of organelles.

Authors:  Leni Moldovan; Nicanor I Moldovan
Journal:  Histochem Cell Biol       Date:  2004-09-25       Impact factor: 4.304

7.  Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells.

Authors:  Hyon-Jeen Kim; Berenice Barajas; Meiying Wang; Andre E Nel
Journal:  J Allergy Clin Immunol       Date:  2008-03-05       Impact factor: 10.793

8.  Plasma antioxidants and human aging: a study on healthy elderly Tunisian population.

Authors:  Olfa Chehab; Mohamed Ouertani; Yosra Souiden; Kamel Chaieb; Kacem Mahdouani
Journal:  Mol Biotechnol       Date:  2008-03-08       Impact factor: 2.695

Review 9.  New imaging tools to measure nephron number in vivo: opportunities for developmental nephrology.

Authors:  K M Bennett; E J Baldelomar; D Morozov; R L Chevalier; J R Charlton
Journal:  J Dev Orig Health Dis       Date:  2020-01-27       Impact factor: 2.401

10.  CaMKII oxidation is a critical performance/disease trade-off acquired at the dawn of vertebrate evolution.

Authors:  Qinchuan Wang; Erick O Hernández-Ochoa; Meera C Viswanathan; Ian D Blum; Danh C Do; Jonathan M Granger; Kevin R Murphy; An-Chi Wei; Susan Aja; Naili Liu; Corina M Antonescu; Liliana D Florea; C Conover Talbot; David Mohr; Kathryn R Wagner; Sergi Regot; Richard M Lovering; Peisong Gao; Mario A Bianchet; Mark N Wu; Anthony Cammarato; Martin F Schneider; Gabriel S Bever; Mark E Anderson
Journal:  Nat Commun       Date:  2021-05-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.